Economic Impact of the Use of Rifaximin 550 Mg Twice Daily for the Treatment of Overt Hepatic Encephalopathy in Italy
Hepatic Medicine: Evidence and Research - New Zealand
doi 10.2147/hmer.s146438
Full Text
Open PDFAbstract
Available in full text
Categories
Date
September 1, 2017
Authors
Publisher
Informa UK Limited